Progress At Pharmaceutical Waste Disposal Site …Medicine, Health Products Regulator Commended

Liberia-Medicines-and-Health-Products-Regulatory-Authority-(LMHRA

The Board of the Liberia Medicines and Health Products Regulatory Authority (LMHRA) has commended the Authority’s management for the significant progress and transformation achieved at its National Pharmaceutical Waste Disposal Site and Ultra-Modern Quality Control Laboratory.

Board Chairperson Victoria Smith-Mulbah made the commendation on Friday, November 13, 2026, during an assessment tour of two major infrastructure projects the Authority is undertaking as part of its ongoing institutional development and capacity-building initiatives.

Speaking during the tour, Pharmacist Smith-Mulbah expressed appreciation to Managing Director Dr. Luke L. Bawo and his management team for the work carried out so far, describing the developments at both facilities as encouraging steps toward strengthening Liberia’s medicines regulatory and public health systems.

The Board delegation visited the LMHRA National Pharmaceutical Waste Disposal Site in Koko Town, Margibi County, and the Authority’s Ultra-Modern Quality Control Laboratory (QCL) in Kings Farm, Careysburg, Montserrado County.

The assessment allowed Board members to see firsthand the progress of the projects, assess their development status, and gain a deeper understanding of their strategic importance to the country’s public health infrastructure.

At the National Pharmaceutical Waste Disposal Site, Managing Director Dr. Bawo briefed the delegation on the progress made, ongoing activities, and the remaining work needed to bring the facility fully into operation.

The pharmaceutical waste disposal facility is expected to play an important role in improving the safe management and disposal of expired, damaged, substandard, and otherwise unusable pharmaceutical products, thereby reducing potential environmental and public health risks associated with improper disposal.

The delegation also toured the Ultra-Modern Quality Control Laboratory, where members saw the progress made toward showing a strengthened national capacity for the testing and quality assessment of medicines and other health products entering and circulating in Liberia.

In her closing remarks, Board Member Dr. Benetor Andrews-Collins reflected on the transformation witnessed at the facilities, recalling that during earlier visits, the sites largely consisted of undeveloped land and an unfinished laboratory structure.

She noted that the scale of development and work conducted since those visits proved the commitment and determination of the Authority’s management to advancing LMHRA’s institutional mandate.

Dr. Andrews-Collins reaffirmed the Board’s commitment to supporting management in completing the projects and ensuring that the Authority has the necessary institutional capacity to effectively discharge its regulatory responsibilities.

The Board’s assessment tour forms part of its oversight responsibilities and reflects its interest in monitoring institutional progress, supporting strategic investments, and ensuring that ongoing infrastructure initiatives translate into tangible improvements in medicines regulation and public health protection.

When fully operational, the two facilities are expected to strengthen Liberia’s capacity to safeguard the quality, safety, and proper management of medicines and health products, while contributing to a more effective and responsive national regulatory system.

Leave a Reply